Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally-Anne Hulton

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Urological Research|March 14, 2009
Primary cultures of renal proximal tubule cells derived from individuals with primary hyperoxaluriaKaren L Price, Sally-Anne Hulton, William G van't Hoff, et al.
Pediatric Nephrology (Berlin, Germany)|July 20, 2007
End-stage renal failure in adolescence with Sjögren's syndrome autoantibodies SSA and SSBSally Johnson, Sally-Anne Hulton, Marie-Anne Brundler, et al.
Pediatric Nephrology (Berlin, Germany)|January 30, 2021
Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studiesDawn S Milliner, Pierre Cochat, Sally-Anne Hulton, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
Renal transplantation in a boy with methylmalonic acidaemiaJoanna Clare Clothier, Anupam Chakrapani, Mary-Anne Preece, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 7, 2004
Urinary L-lactate excretion is increased in renal Fanconi syndromeArumugavelu Thirumurugan, Andrew Thewles, Rodney D Gilbert, et al.
Kidney International|July 3, 2014
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation typeGiorgia Mandrile, Christiaan S van Woerden, Paola Berchialla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2011
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluriaBernd Hoppe, Jaap W Groothoff, Sally-Anne Hulton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapyJérôme Harambat, Karlijn J van Stralen, Laura Espinosa, et al.
Pediatric Nephrology (Berlin, Germany)|December 8, 2016
A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluriaBernd Hoppe, Patrick Niaudet, Rémi Salomon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Urological Research|March 14, 2009
Primary cultures of renal proximal tubule cells derived from individuals with primary hyperoxaluriaKaren L Price, Sally-Anne Hulton, William G van't Hoff, et al.
Pediatric Nephrology (Berlin, Germany)|July 20, 2007
End-stage renal failure in adolescence with Sjögren's syndrome autoantibodies SSA and SSBSally Johnson, Sally-Anne Hulton, Marie-Anne Brundler, et al.
Pediatric Nephrology (Berlin, Germany)|January 30, 2021
Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studiesDawn S Milliner, Pierre Cochat, Sally-Anne Hulton, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
Renal transplantation in a boy with methylmalonic acidaemiaJoanna Clare Clothier, Anupam Chakrapani, Mary-Anne Preece, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 7, 2004
Urinary L-lactate excretion is increased in renal Fanconi syndromeArumugavelu Thirumurugan, Andrew Thewles, Rodney D Gilbert, et al.
Kidney International|July 3, 2014
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation typeGiorgia Mandrile, Christiaan S van Woerden, Paola Berchialla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2011
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluriaBernd Hoppe, Jaap W Groothoff, Sally-Anne Hulton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapyJérôme Harambat, Karlijn J van Stralen, Laura Espinosa, et al.
Pediatric Nephrology (Berlin, Germany)|December 8, 2016
A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluriaBernd Hoppe, Patrick Niaudet, Rémi Salomon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
Pageof 4